![Yusuke Nakamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 6 Mio $ am 31.07.2026
Yusuke Nakamura is currently the President of the National Institutes of Biomedical Innovation, Health & Nutrition.
He previously worked as a Director at OncoTherapy Science, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
20.53% | 31.10.2025 | 1’000’000 ( 20.53% ) | 4 Mio $ | 31.07.2026 |
| 30.09.2025 | 12’511’000 ( 3.06% ) | 1 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Natl Institutes of Biomedical Innovation, Health & Nutrition
 Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | Präsident | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
OncoTherapy Science, Inc.
 OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
Natl Institutes of Biomedical Innovation, Health & Nutrition
Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | Government |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
